<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01824030</url>
  </required_header>
  <id_info>
    <org_study_id>6261/13</org_study_id>
    <nct_id>NCT01824030</nct_id>
  </id_info>
  <brief_title>FFR or OCT Guidance to RevasculariZe Intermediate Coronary Stenosis Using Angioplasty</brief_title>
  <acronym>FORZA</acronym>
  <official_title>FFR or OCT Guidance to RevasculariZe Intermediate Coronary Stenosis Using Angioplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Catholic University of the Sacred Heart</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Catholic University of the Sacred Heart</source>
  <brief_summary>
    <textblock>
      Whether to revascularize patients with angiographically-intermediate coronary lesions (AICL)
      is a major clinical issue. Intravascular techniques (assessing either the anatomy or the
      functional effect of coronary stenoses) are routinely used to better characterize coronary
      lesions. Among these,fractional flow reserve (FFR) provides validated functional insights
      while optical coherence tomography (OCT) provides high resolution anatomic imaging. Both
      techniques may be applied to guide decisions regarding the opportunity to revascularize
      patients with AICL and to optimize the result of percutaneous coronary intervention (PCI). We
      aim to compare the clinical and the economical impact of FFR versus OCT guidance in the
      percutaneous management of patients with AICL.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">April 2016</completion_date>
  <primary_completion_date type="Anticipated">April 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Occurrence of angina defined as Seattle Angina Questionnaire score &lt; 90 in angina frequency scale, at 13 month follow up from index procedure*</measure>
    <time_frame>13 months</time_frame>
    <description>*In case of MACE rate absolute difference of &gt;1% between the two study arms, the primary end-point will be: &quot;Occurrence of Major Cardiovascular Event and angina defined as Seattle Angina Questionnaire score &lt; 90 in angina frequency scale, at 13 months follow up from index procedure&quot;</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Occurrence of Major Cardiovascular Event and angina defined as Seattle Angina Questionnaire score &lt; 90 in angina frequency scale, at 13 months follow up from index procedure</measure>
    <time_frame>13 months</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Periprocedural costs</measure>
    <time_frame>30 days</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Periprocedural costs</measure>
    <time_frame>13 months</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Ischemic Heart Disease</condition>
  <arm_group>
    <arm_group_label>FFR guided PCI arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with angiographic intermediate coronary artery stenosis randomized to FFR assessment. PCI performed only if FFR ≤ 0.80</description>
  </arm_group>
  <arm_group>
    <arm_group_label>OCT guided PCI arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with angiographic intermediate coronary artery stenosis randomized to OCT. PCI will be performed if:
percentage area stenosis ≥75 %
percentage area stenosis between 50 and 75% and minimal lumen area &lt;2.5 mm2
percentage area stenosis between 50 and 75% and major plaque ulceration</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>FFR guided PCI</intervention_name>
    <description>FFR to assess coronary artery stenosis severity and indication to perform and eventually optimize percutaneous coronary intervention</description>
    <arm_group_label>FFR guided PCI arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>OCT guided PCI</intervention_name>
    <description>OCT to assess coronary artery stenosis severity and indication to perform and eventually optimize percutaneous coronary intervention</description>
    <arm_group_label>OCT guided PCI arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  single vessel disease with an intermediate coronary artery stenosis

          -  multivessel disease with multiple intermediate coronary artery stenosis only

          -  multivessel disease with already treated angiographically critical stenosis and at
             least one intermediate coronary artery stenosis

        Exclusion Criteria:

          -  age &lt;18 years or impossibility to give informed consent,

          -  female sex with child-bearing potential,

          -  life expectancy of less than 12 months or factors making clinical follow-up difficult
             (no fixed address, etc),

          -  poor cardiac function as defined by left ventricular global ejection fraction ≤ 30%

          -  recent (&lt; 7 days) ST-segment elevation myocardial infarction

          -  recent (&lt; 48 hours) Non ST-segment elevation myocardial infarction

          -  prior ST-segment elevation myocardial infarction in the territory supplied by the
             vessel with the intermediate stenosis under investigation

          -  severe myocardial hypertrophy (interventricular septum thickness &gt; 15 mm, ECG
             Sokolow's criteria fulfilled)

          -  severe valvular heart disease

          -  significant platelet count alteration (&lt;100,000 cells/mm3 or &gt; 700,000 cells/mm3)

          -  gastrointestinal bleeding requiring surgery or blood transfusions within 4 previous
             weeks

          -  history of clotting pathology

          -  known hypersensitivity to aspirin, heparin, contrast dye

          -  advance renal failure with glomerular filtration rate &lt; 30 ml/min

          -  lesions in coronary artery bypass grafts

          -  multivessel disease requiring coronary aortic bypass graft intervention
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Francesco Burzotta, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Università Cattolica del Sacro Cuore, Roma</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Francesco Burzotta, MD, PhD</last_name>
    <phone>+39 3494295290</phone>
    <email>f.burzotta@rm.unicatt.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Policlinico A. Gemelli. Università Cattolica del Sacro Cuore</name>
      <address>
        <city>Rome</city>
        <zip>00168</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesco Burzotta, MD, PhD</last_name>
      <phone>349-429-5290</phone>
      <phone_ext>+39</phone_ext>
      <email>f.burzotta@rm.unicatt.it</email>
    </contact>
    <investigator>
      <last_name>Francesco Burzotta, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 28, 2013</study_first_submitted>
  <study_first_submitted_qc>April 1, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 4, 2013</study_first_posted>
  <last_update_submitted>April 8, 2013</last_update_submitted>
  <last_update_submitted_qc>April 8, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 9, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Catholic University of the Sacred Heart</investigator_affiliation>
    <investigator_full_name>Francesco Burzotta</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>FFR, OCT, Seattle Angina Questionnaire</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Coronary Stenosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

